$Eli Lilly(LLY)$ In Big Pharma's growth rankings Eli Lilly took top spot away from Novo Nordisk in Q1
and they will do it again in Q2.
NVO $Novo-Nordisk A/S(NVO)$ missed. Lilly won't miss
Facts matter! Look at last quarter to see how it played out.
Q1: Novo Nordisk dropped out of the top spot with its 22% YOY increase
Lilly took over as No. 1 thanks to its 28% quarterly boost.
They will do it again and beat NVO
Think Winnie The Pooh GIF
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
